The US health regulator is delaying a decision on authorizing Moderna Inc's COVID-19 vaccine for adolescents to assess whether the shot may lead to heightened risk of heart inflammation, the Wall Street Journal reported on Friday, citing people familiar with the matter.
US FDA delays decision on Moderna's COVID-19 vaccine for adolescents
By MAARIV
03/03/2025 06:07 AM
By WALLA!
03/03/2025 04:31 AM
By MAARIV
03/03/2025 01:18 AM
By REUTERS
03/03/2025 01:06 AM
By REUTERS
03/02/2025 11:44 PM
By REUTERS
03/02/2025 07:37 PM
By REUTERS
03/02/2025 07:34 PM
By REUTERS
03/02/2025 05:56 PM
By REUTERS
03/02/2025 05:53 PM